scholarly journals Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer

2012 ◽  
Vol 70 (5) ◽  
pp. 727-734 ◽  
Author(s):  
Colm Farrell ◽  
Charles Schweizer ◽  
Jason Wustner ◽  
Susan Weil ◽  
Masayuki Namiki ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Epithelial Ovarian Cancer ◽  
Population Pharmacokinetics ◽  
Folate Receptor ◽  
Folate Receptor Alpha ◽  
Receptor Alpha ◽  
Humanized Monoclonal Antibody

scholarly journals Farletuzumab, a Humanized Monoclonal Antibody against Folate Receptor α, in Epithelial Ovarian Cancer: a Phase I Study

2010 ◽  
Vol 16 (21) ◽  
pp. 5288-5295 ◽  
Author(s):  
Jason A. Konner ◽  
Katherine M. Bell-McGuinn ◽  
Paul Sabbatini ◽  
Martee L. Hensley ◽  
William P. Tew ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Phase I Study ◽  
Folate Receptor ◽  
Humanized Monoclonal Antibody

Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer

2016 ◽  
Vol 25 (12) ◽  
pp. 1405-1412 ◽  
Author(s):  
Alice Bergamini ◽  
Simone Ferrero ◽  
Umberto Leone Roberti Maggiore ◽  
Carolina Scala ◽  
Francesca Pella ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Early Stage ◽  
Folate Receptor ◽  
Clinical Development ◽  
Folate Receptor Alpha ◽  
Receptor Alpha

Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer

2013 ◽  
Vol 129 (3) ◽  
pp. 452-458 ◽  
Author(s):  
Deborah K. Armstrong ◽  
Allen J. White ◽  
Susan C. Weil ◽  
Martin Phillips ◽  
Robert L. Coleman
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Folate Receptor ◽  
Folate Receptor Alpha ◽  
Receptor Alpha ◽  
Platinum Sensitive
Sign in / Sign up

Export Citation Format

Share Document